The upgrade from Neutral to Overweight by Cantor Fitzgerald indicates a positive outlook for Ardelyx. The doubling of the price target from $5 to $10 suggests that the analyst sees significant upside potential for the stock. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.